These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30566697)

  • 1. Innovation in Neovascular Age-Related Macular Degeneration: Consideration of Brolucizumab, Abicipar, and the Port Delivery System.
    Wykoff CC; Hariprasad SM; Zhou B
    Ophthalmic Surg Lasers Imaging Retina; 2018 Dec; 49(12):913-917. PubMed ID: 30566697
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravitreal bevacizumab in advanced-stage neovascular age-related macular degeneration with visual acuity lower than 20/200.
    Parodi MB; Cascavilla M; Papayannis A; Kontadakis DS; Bandello F; Iacono P
    Arch Ophthalmol; 2012 Jul; 130(7):934-5. PubMed ID: 22776937
    [No Abstract]   [Full Text] [Related]  

  • 3. Incidence of Charles Bonnet syndrome after intravitreal bevacizumab injection in neovascular age-related macular degeneration.
    Zhang H; Liu ZL; Sun P; Gu F
    Acta Ophthalmol; 2012 Dec; 90(8):e647-8. PubMed ID: 22490079
    [No Abstract]   [Full Text] [Related]  

  • 4. Radiotherapy for anti-vascular endothelial growth factor injections for neovascular age-related macular degeneration.
    Ying GS; VanderBeek BL
    Lancet; 2024 Jul; 404(10447):4-5. PubMed ID: 38876134
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-vascular endothelial growth factor injection technique for recurrent exudative macular degeneration in a telescope-implanted eye.
    Joondeph BC
    Retin Cases Brief Rep; 2014; 8(4):342-4. PubMed ID: 25372544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brolucizumab (Beovu) for age-related macular degeneration.
    Med Lett Drugs Ther; 2020 Feb; 62(1591):23-24. PubMed ID: 32022789
    [No Abstract]   [Full Text] [Related]  

  • 7. Current state of therapeutic strategies with ranibizumab in neovascular age-related macular degeneration.
    Gallego-Pinazo R; Figueroa MS; García-Layana A
    Curr Opin Ophthalmol; 2015 May; 26(3):200-5. PubMed ID: 25774961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retreatment with anti-vascular endothelial growth factor therapy based on changes in visual acuity after initial stabilization of neovascular age-related macular degeneration: 3-year follow-up results.
    Dunavoelgyi R; Sacu S; Eibenberger K; Palkovits S; Leydolt C; Pruente C; Schmidt-Erfurth U
    Retina; 2012 Sep; 32(8):1471-9. PubMed ID: 22414958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recalcitrant neovascular macular degeneration after anti-VEGF therapy: an ongoing challenge.
    Puliafito CA
    Ophthalmic Surg Lasers Imaging Retina; 2013; 44(2):109. PubMed ID: 23510034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular Therapeutics and Molecular Delivery Strategies for Neovascular Age-Related Macular Degeneration (nAMD).
    Sarkar A; Junnuthula V; Dyawanapelly S
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treat-and-extend bevacizumab for neovascular age-related macular degeneration: the importance of baseline characteristics.
    Rush RB; Simunovic MP; Vandiver L; Aragon AV; Ysasaga JE
    Retina; 2014 May; 34(5):846-52. PubMed ID: 24240560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of AMD treatment response.
    Wickremasinghe SS; Sandhu SS; Busija L; Lim J; Chauhan DS; Guymer RH
    Ophthalmology; 2012 Nov; 119(11):2413-2414.e5. PubMed ID: 23122466
    [No Abstract]   [Full Text] [Related]  

  • 13. Brolucizumab Versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration: A Randomized Trial.
    Dugel PU; Jaffe GJ; Sallstig P; Warburton J; Weichselberger A; Wieland M; Singerman L
    Ophthalmology; 2017 Sep; 124(9):1296-1304. PubMed ID: 28551167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical predictors of sustained intraocular pressure elevation due to intravitreal anti-vascular endothelial growth factor therapy.
    Hoang QV; Tsuang AJ; Gelman R; Mendonca LS; Della Torre KE; Jung JJ; Freund KB
    Retina; 2013 Jan; 33(1):179-87. PubMed ID: 22990314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translational public health care perspective: intravitreal treatment of neovascular age-related macular degeneration has revolutionized clinical ophthalmology.
    Bloch SB; Larsen M
    Acta Ophthalmol; 2015 Mar; 93(2):103-4. PubMed ID: 25688486
    [No Abstract]   [Full Text] [Related]  

  • 16. Retinal venular calibre dilatation after intravitreal ranibizumab treatment for neovascular age-related macular degeneration.
    Wickremasinghe SS; Guymer RH; Wong TY; Kawasaki R; Wong W; Qureshi S
    Clin Exp Ophthalmol; 2012; 40(1):59-66. PubMed ID: 21668787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of 12-month treatment of neovascular age-related macular degeneration with intravitreal bevacizumab based on individually determined injection strategies after three consecutive monthly injections.
    Mekjavic PJ; Kraut A; Urbancic M; Lenassi E; Hawlina M
    Acta Ophthalmol; 2011 Nov; 89(7):647-53. PubMed ID: 19860774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal ranibizumab injection for neovascular age-related macular degeneration in phakic versus pseudophakic eyes.
    Baek JS; Cho HJ; Cho SW; Kim CG; Kim JW
    Retina; 2013 Mar; 33(3):467-73. PubMed ID: 23400082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is This a 737 Max Moment for Brolucizumab?
    Rosenfeld PJ; Browning DJ
    Am J Ophthalmol; 2020 Aug; 216():A7-A8. PubMed ID: 32505363
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of intravitreal bevacizumab on retrobulbar blood flow in injected and uninjected fellow eyes of patients with neovascular age-related macular degeneration.
    Hosseini H; Lotfi M; Esfahani MH; Nassiri N; Khalili MR; Razeghinejad MR; Nouri-Mahdavi K
    Retina; 2012 May; 32(5):967-71. PubMed ID: 22146127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.